MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Clearside Biomedical Inc

Închisă

0.83 2.47

Rezumat

Modificarea prețului

24h

Curent

Minim

0.81

Maxim

0.86

Indicatori cheie

By Trading Economics

Venit

-917K

-8.2M

Vânzări

2M

2.3M

Marjă de profit

-352.918

Angajați

32

EBITDA

-102K

-4.8M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+550.6% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-53K

69M

Deschiderea anterioară

-1.64

Închiderea anterioară

0.83

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Clearside Biomedical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 iul. 2025, 23:56 UTC

Achiziții, Fuziuni, Preluări

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- 2nd Update

16 iul. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Output Rises 1% as Takeover Campaign Continues

16 iul. 2025, 23:00 UTC

Achiziții, Fuziuni, Preluări

Alimentation Couche-Tard Ends Bid to Buy Seven & I Holdings -- Update

16 iul. 2025, 22:38 UTC

Achiziții, Fuziuni, Preluări

Alimentation Couche-Tard Withdraws Seven & i Acquisition Proposal

16 iul. 2025, 23:44 UTC

Market Talk

Gold Steady; Geopolitical Tensions in Middle East Support -- Market Talk

16 iul. 2025, 23:42 UTC

Market Talk

Nikkei May Fall as Yen Strengthens -- Market Talk

16 iul. 2025, 23:24 UTC

Market Talk

Australian Job Market Data to Shape RBA Calls -- Market Talk

16 iul. 2025, 23:18 UTC

Achiziții, Fuziuni, Preluări

Santos Now Expects 2025 Production of 90 Million-95 Million BOE

16 iul. 2025, 23:18 UTC

Achiziții, Fuziuni, Preluări

Santos Cuts Top End of 2025 Production Guidance

16 iul. 2025, 23:17 UTC

Achiziții, Fuziuni, Preluări

Santos: Production Recovery Underway in Cooper Basin

16 iul. 2025, 23:17 UTC

Achiziții, Fuziuni, Preluări

Santos: Over 200 Wells, Several Upstream Compressors in Cooper Basin Shut In

16 iul. 2025, 23:17 UTC

Achiziții, Fuziuni, Preluări

Santos: Cooper Basin Production Impacted by Floods in 2Q

16 iul. 2025, 23:16 UTC

Achiziții, Fuziuni, Preluări

Santos: Pikka Phase 1 Project in Alasia 89% Complete

16 iul. 2025, 23:16 UTC

Achiziții, Fuziuni, Preluări

Santos Keeps 2025 Major Development Project Capex Guidance Unchanged

16 iul. 2025, 23:13 UTC

Achiziții, Fuziuni, Preluări

Santos Had Gearing of 20.5% at End-June, Excluding Operating Leases

16 iul. 2025, 23:13 UTC

Achiziții, Fuziuni, Preluări

Santos Says Moomba CCS Phase 1 Project Performing to Expectations

16 iul. 2025, 23:12 UTC

Achiziții, Fuziuni, Preluări

Santos Narrows 2025 Unit Production Cost Guidance to US$7.00-US$7.40/BOE

16 iul. 2025, 23:12 UTC

Achiziții, Fuziuni, Preluări

Santos 1H Free Cash Flow From Operations US$1.1 Billion

16 iul. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Free Cash Flow From Operations US$620 Million

16 iul. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Oil, Natural Gas Output 22.2 Million BOE

16 iul. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Oil, Natural Gas Sales Volumes 23.9 Million BOE

16 iul. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Oil, Natural Gas Sales Volumes Up 3% on 1Q

16 iul. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Santos 2Q Oil, Natural Gas Output Up 1% on 1Q

16 iul. 2025, 22:43 UTC

Market Talk

Alcoa Using High Costs of More Production to Battle Tariff -- Market Talk

16 iul. 2025, 22:35 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

16 iul. 2025, 22:35 UTC

Market Talk
Câștiguri

Replacing Aluminum Imports With U.S. Production Not Seen Feasible -- Market Talk

16 iul. 2025, 22:33 UTC

Market Talk
Câștiguri

Alcoa Will Continue to Ship Aluminum Outside of the U.S. -- Market Talk

16 iul. 2025, 22:28 UTC

Market Talk
Câștiguri

Aluminum Price in U.S. Doesn't Offset Tariff Costs, Alcoa says -- Market Talk

16 iul. 2025, 22:22 UTC

Market Talk
Câștiguri

Market Talk Roundup: Latest on U.S. Politics

16 iul. 2025, 22:22 UTC

Market Talk
Câștiguri

Alcoa Considers Restart of Idle Capacity at Indiana Smelter -- Market Talk

Comparație

Modificare preț

Clearside Biomedical Inc Așteptări

Obiectiv de preț

By TipRanks

550.6% sus

Prognoză pe 12 luni

Medie 5.4 USD  550.6%

Maxim 8 USD

Minim 3 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruClearside Biomedical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

5

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

0.8417 / 0.8939Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.